Home > Insider Trading > Filing (0001209191-16-122335)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591976	A Steven Ross	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	Cio	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-18	18,000	$4.78	22,500	No	4	M	Direct
Common Stock	Disposition	2016-05-18	18,000	$8.50	4,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Disposition	2016-05-18	18,000	$4.78	18,000	$4.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
67,000	2016-05-06	2020-05-06	No	4	X	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,500	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock option (Right to buy)	$7.15	2017-04-20	2021-04-20	40,000	40,000	Direct
Common Stock	Stock Option (Right to buy)	$3.93	2014-04-22	2018-04-22	37,500	37,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-20	40,000	40,000	Direct
2018-04-22	37,500	37,500	Direct

Footnotes

On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On April 22, 2013, Mr. Ross was granted 150,000 options to purchase common stock of the Company. These options vest ratably on each of the next four anniversary dates of the grant date. On April 29, 2016, Mr. Ross exercised 112,500 of these options leaving a balance of 37,500.
On May 6, 2015, Mr. Ross was granted 100,000 stock options to purchase common stock of the Company. These options vest ratably on each of the first three anniversary dates of the grant date. On May 9, 2016, Mr. Ross exercised 15,000 of these options and on May 18, 2016 Mr. Ross exercised 18,000 options leaving a balance of 67,000 options.